Authors:
VERGIS E
MONTESSORI V
MONTANER J
MELLORS J
Citation: E. Vergis et al., INTERNATIONAL WORKSHOP ON SALVAGE THERAPY FOR HIV-INFECTION - NEW-ORLEANS, LOUISIANA - USA, 16-18 APRIL 1998, Antiviral therapy, 3, 1998, pp. 1-22
Authors:
SAAH AJ
HOOVER DR
WENG SG
CARRINGTON M
MELLORS J
RINALDO CR
MANN D
APPLE R
PHAIR JP
DETELS R
OBRIEN S
ENGER C
JOHNSON P
KASLOW RA
Citation: Aj. Saah et al., ASSOCIATION OF HLA PROFILES WITH EARLY PLASMA VIRAL LOAD, CD4-1 INFECTION( CELL COUNT AND RATE OF PROGRESSION TO AIDS FOLLOWING ACUTE HIV), AIDS, 12(16), 1998, pp. 2107-2113
Authors:
GUPTA P
MELLORS J
KINGSLEY L
RIDDLER S
SINGH MK
SCHREIBER S
CRONIN M
RINALDO CR
Citation: P. Gupta et al., HIGH VIRAL LOAD IN SEMEN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED MEN AT ALL STAGES OF DISEASE AND ITS REDUCTION BY THERAPY WITH PROTEASE AND NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS, Journal of virology, 71(8), 1997, pp. 6271-6275
Authors:
ROSOWSKY A
FU HN
PAI N
MELLORS J
RICHMAN DD
HOSTETLER KY
Citation: A. Rosowsky et al., SYNTHESIS AND IN-VITRO ACTIVITY OF LONG-CHAIN XYCARBONYL)PHOSPHINYL]-3'-AZIDO-3'-DEOXYTHYMIDINES AGAINST WILD-TYPE AND AZT-RESISTANT AND FOSCARNET-RESISTANT STRAINS OF HIV-1, Journal of medicinal chemistry, 40(16), 1997, pp. 2482-2490
Authors:
CAMERON DW
HSU A
GRANNEMAN GR
SUN E
MCMAHON D
FARTHING C
PORETZ D
MARKOWTIZ M
COHEN C
FOLLANSBEE S
MELLORS J
HO D
XU Y
RODE R
SALGO M
LEONARD J
Citation: Dw. Cameron et al., PHARMACOKINETICS OF RITONAVIR-SAQUINAVIR COMBINATION THERAPY, AIDS, 10, 1996, pp. 56-56
Authors:
TACHEDJIAN G
MELLORS J
BAZMI H
BIRCH C
MILLS J
Citation: G. Tachedjian et al., ZIDOVUDINE RESISTANCE IS SUPPRESSED BY MUTATIONS CONFERRING RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO FOSCARNET, Journal of virology, 70(10), 1996, pp. 7171-7181
Authors:
ACERBI E
BACCAGLIONI G
ROSSI L
VOLPINI G
BILTCLIFFE M
DANIELS P
MELLORS J
TIMMS K
Citation: E. Acerbi et al., DESIGN AND EXPERIMENTAL RESULTS OF THE NB3SN DOUBLE INSERT FOR AN 18-TESLA, 100-MM FREE BORE SOLENOID, IEEE transactions on magnetics, 32(4), 1996, pp. 2554-2557
Authors:
ARNOLD E
DAS K
DING JP
HSIOU Y
TANTILLO C
ROY BM
YADAV P
ZHANG WY
LENTZ K
CLARK AD
BOYER PL
HUGHES SH
MITSUYA H
MELLORS J
KLEIM JP
ROSNER M
MOEREELS HR
KOYMANS L
ANDRIES K
PAUWELS R
JANSSEN PAJ
Citation: E. Arnold et al., THE ROLE OF NUCLEIC-ACID IN THE RESISTANCE OF HIV-1 REVERSE-TRANSCRIPTASE TO NUCLEOSIDE AND NONNUCLEOSIDE INHIBITORS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 7-7
Authors:
GRAHAM NMH
PARK LP
PIANTADOSI S
PHAIR JP
MELLORS J
FAHEY JL
SAAH AJ
Citation: Nmh. Graham et al., PROGNOSTIC VALUE OF COMBINED RESPONSE MARKERS AMONG HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS - POSSIBLE AID IN THE DECISION TO CHANGE ZIDOVUDINE MONOTHERAPY, Clinical infectious diseases, 20(2), 1995, pp. 352-362
Authors:
COWEY L
CETNIK P
TIMMS K
DANIELS P
MELLORS J
MCDOUGALL I
Citation: L. Cowey et al., CRYOGEN FREE NB3SN MAGNET, OPERATED AT 9.5 K WITH HIGH T-C BISRCACUO(2212) CURRENT LEADS, IEEE transactions on applied superconductivity, 5(2), 1995, pp. 825-827
Authors:
GUPTA P
DING M
COTTRILL M
RINALDO C
KINGSLEY L
WOLINSKY S
MELLORS J
Citation: P. Gupta et al., QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA AND RNA BY A NOVEL INTERNALLY CONTROLLED PCR ASSAY, Journal of clinical microbiology, 33(6), 1995, pp. 1670-1673
Authors:
TACHEDJIAN G
HOOKER DJ
GURUSINGHE AD
BAZMI H
DEACON NJ
MELLORS J
BIRCH C
MILLS J
Citation: G. Tachedjian et al., CHARACTERIZATION OF FOSCARNET-RESISTANT STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Virology, 212(1), 1995, pp. 58-68
Citation: J. Mellors, THE COMMERCIALIZATION OF COMMON SERVICES PROVIDED BY THE DEPARTMENT OF ADMINISTRATIVE SERVICES - OUTCOMES AND EMERGING ISSUES, Australian journal of public administration, 52(3), 1993, pp. 329-338